Fundraising Fox
Cx Precision Medicine
Fort Worth, US · Founded 2016 · Delaware corporation · 1 known investors
Find your way into Cx Precision Medicine
Sign up to see every warm intro you have to Cx Precision Medicine
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cx Precision Medicine team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cx Precision Medicine develops blood-based diagnostic tests for Alzheimer's and other neurodegenerative diseases, delivering precision medicine tools for early diagnosis and personalized treatment in primary care settings.
Founders & leadership
Cx Precision Medicine was founded in 2016 by Sid O'Bryant.
SO
Sid O'BryantScientific Founder, Executive Director of the Institute for Translational Research
FG
Frank GeromePresident and CEO2015–2017Frank Gerome is Director, CEO and President of Cx Precision Medicine, which develops blood-based diagnostic tests for Alzheimer's and other neurodegenerative diseases. He has held operating roles in general management, sales, operations, and finance across multiple sectors and company stages, including turnaround and private equity environments.
Investors · 1
Reported raises · per SEC filings
Form D private placements$3M disclosed across 4 of 5 rounds · 2016–2024
▶$4MofferedJun 2024 · Other Health CareRule 506(b)
▶$4MofferedJun 2024 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Darlene BoudreauxExecutive Officer
- Cameron CushmanDirector
- Robert FergusonDirector
- Danguole AltmanExecutive Officer, Director
- Edward LasaterDirector
- Donald Jeff KeyserDirector
- Offering amount
- $4M
- Proceeds to insiders
- $324K
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.2MraisedDec 2022 · 25 investors · Other Health CareRule 506(b)
▶$1.2MraisedDec 2022 · 25 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Cameron CushmanDirector
- Robert FergusonExecutive Officer, Director
- Danguole AltmanExecutive Officer, Director
- Edward LasaterExecutive Officer, Director
- Jeff KeyserDirector
- Offering amount
- $3M
- Amount sold
- $1.2M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$934.1KraisedAug 2021 · 12 investors · Other Health CareRule 506(b)
▶$934.1KraisedAug 2021 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Danguole AltmanExecutive Officer, Director
- Cameron CushmanDirector
- Robert FergusonExecutive Officer, Director
- Edward LasaterExecutive Officer, Director
- Offering amount
- $1.3M
- Amount sold
- $934.1K
- Proceeds to insiders
- $220K
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$600KraisedAug 2020 · 13 investors · Other Health CareRule 506(b)
▶$600KraisedAug 2020 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Cameron CushmanDirector
- Danguole AltmanExecutive Officer
- Robert FergusonExecutive Officer, Director
- Edward LasaterExecutive Officer, Director
- Offering amount
- $600K
- Amount sold
- $600K
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$250KraisedAug 2016 · 1 investors · BiotechnologyRule 506(b)
▶$250KraisedAug 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Frank GeromeExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $250K
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Precision Medicine Group, Inc.Precision Medicine Group provides biomarker-driven research and development services and commercialization support for pharmaceutical and life science companies across drug development, manufacturing, and market access.
ConcentrixConcentrix is an enterprise services provider that designs, builds, and operates intelligent business models and digital operations for large organizations. The company serves multiple industries including automotive, banking, healthcare, retail, and technology through strategy, data analytics, customer experience design, and technology engineering services.
Precision For MedicinePrecision for Medicine is a contract research organization that provides clinical trial management and regulatory support for drug development programs, including oncology, hematology, cell and gene therapy, CAR-T, and radiopharmaceutical trials. It serves pharmaceutical and biotech sponsors running multinational Phase I–IV studies.
Companies working in the same space as Cx Precision Medicine.
Frequently asked questions
- What does Cx Precision Medicine do?
- Cx Precision Medicine develops blood-based diagnostic tests for Alzheimer's and other neurodegenerative diseases, delivering precision medicine tools for early diagnosis and personalized treatment in primary care settings.
- Who founded Cx Precision Medicine?
- Cx Precision Medicine was founded by Sid O'Bryant in 2016.
- Who are Cx Precision Medicine's investors?
- Cx Precision Medicine's investors include Cowtown Angels.
- How much funding has Cx Precision Medicine raised?
- Cx Precision Medicine has disclosed $3M raised across 4 of its 5 known rounds.
- Where is Cx Precision Medicine headquartered?
- Cx Precision Medicine is headquartered in Fort Worth, US.